Robin Kroll

No ORCID on file · 3 papers in corpus · active 2009-2024

Study types

  • rct 2
  • article 1

Condition tags

  • endometriosis 2
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • dyspareunia 1
rct
Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000005380

OBJECTIVE: To evaluate the safety and efficacy of elagolix 150 mg once-daily monotherapy in patients with heavy menstrual bleeding associated with uterine leiomyomas. METHODS: A phase 4, randomized, double-blind, placebo-controlled, 6-mont…

rct 2024
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2024.06.040

BACKGROUND: Elagolix, an approved oral treatment for endometriosis-associated pain, has been associated with hypoestrogenic effects when used as monotherapy. Hormonal add-back therapy has the potential to mitigate these effects. OBJECTIVE:…

article 2009
Petal study: safety, tolerability and effectiveness of elagolix, an oral GnRH antagonist for endometriosis
·doi:10.1016/j.fertnstert.2009.07.1100